1Point Pharma ApS: Financial statements 2025

CVR: 44804425

1Point Pharma ApS (CVR 44804425) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,313,951 and a net result of DKK -1,484,861. Equity amounted to DKK 932,458. The solvency ratio was 27%. The company had 4 employees in the financial year.

Gross Profit: -1,313,951 kr.
Profit/Loss: -1,484,861 kr.
Equity: 932,458 kr.
Total Assets: 3,450,752 kr.
Employees: 4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like 1Point Pharma ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

1Point Pharma ApS publishes interim reportJun 25, 2025

1Point Pharma ApS has published its interim report for the period April 29, 2024 – December 31, 2024.

About 1Point Pharma ApS

1Point Pharma ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2024. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Morten Carl Madsen. The company's owners include Holdingselskabet House of Lundorff APS, Lease-A-Brain ApS and GJ Invest ApS. In 2025, the company reported a gross profit of DKK -1,313,951 and a net result of DKK -1,484,861. Equity amounted to DKK 932,458.